Cover Image
市場調查報告書

臨床用營養產品的全球市場

Clinical Nutrition Products

出版商 Global Industry Analysts, Inc. 商品編碼 121181
出版日期 內容資訊 英文 388 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
臨床用營養產品的全球市場 Clinical Nutrition Products
出版日期: 2015年01月01日 內容資訊: 英文 388 Pages
簡介

本報告提供全球臨床用營養產品市場相關調查,提供產業趨勢,各地區趨勢,預測,加入此市場的主要企業簡介等彙整資料,為您概述為以下內容。

第1章 簡介,方法,產品定義

第2章 摘要整理

  • 產業概要
    • 臨床用營養產品市場鳥瞰圖
    • 新興市場:再度受到注目的成長市場
    • 嬰兒用營養產品:商店內急速成長
    • 嬰幼兒配方奶粉市場:新興市場推動成長
    • 競爭情形
    • 經腸營養法市場
    • 非口服的營養市場
  • 推動市場的要素,趨勢,課題
    • 不景氣的影響:檢討·展望
    • 醫療費的改善促進需求
    • 高齡化:強力促進成長要素
    • 慢性疾病的發病率上升刺激市場成長
    • 全球癌症統計:發病率和死亡率資料
    • 糖尿病:又一個重要的慢性疾病
    • 全球HIV統計,其他
  • 產品概要
    • 臨床營養:簡介
    • 給予臨床營養的疾病
    • 臨床營養的優點
    • 臨床營養產品的分類
    • 嬰兒營養產品
    • 經腸營養
    • 非口服營養產品
  • 產品創新/投入/認證
  • 近幾年的產業活動
  • 主要企業
    • Abbott Nutrition
    • American HomePatient, Inc.
    • Baxter International, Inc.
    • B. Braun Melsungen AG
    • Claris Lifesciences Ltd.
    • Groupe Danone
    • Nutricia North America
    • Fresenius Kabi AG
    • Hospira, Inc.
    • Mead Johnson Nutrition Company
    • 株式會社明治
    • Nestle Health Science S.A
    • 大塚製藥株式會社
    • Sino-Swed Pharmaceutical Corp, Ltd.
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
    • 其他
  • 亞太地區各國
    • 中國
    • 印度
    • 其他
  • 中東·非洲
  • 南美
    • 巴西
    • 墨西哥
    • 其他

第4章 競爭情形

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-6353

This report analyzes the worldwide markets for Clinical Nutrition Products in US$ Million by the following Product Segments: Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa, and Latin America. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 64 companies including many key and niche players such as -

Abbott Nutrition
American HomePatient, Inc.
Baxter International, Inc.
B. Braun Melsungen AG
Claris Lifesciences Ltd.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • 1. Enteral Nutrition
    • 2. Infant Nutrition
    • 3. Parenteral Nutrition

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • A Bird's Eye View of the Clinical Nutrition Products Market
  • Emerging Markets: The New Hotspots for Growth
    • Table 1: GDP Growth for Key Developed and Developing Countries: 2003-2013 (includes corresponding Graph/Chart)
  • Infant Nutrition: Rapid Growth in Store
  • Infant Formula Market: Emerging Markets to Drive Growth
  • Competitive Landscape
    • Table 2: Leading Players in the Global Clinical Nutrition Market (2013): Percentage Breakdown of Value Sales for Abbott Nutrition, Danone, Fresenius Kabi, Nestle, and Others (includes corresponding Graph/Chart)
    • Table 3: Leading Players in the Global Infant Formula Market (2013): Percentage Share Breakdown of Volume Sales by Manufacturer (includes corresponding Graph/Chart)
  • Enteral Nutrition Market
    • Table 4: Leading Players in the Global Enteral Nutrition Market (2013): Percentage Breakdown of Value Sales for Abbott, Nestle, Danone, Fresenius and Others (includes corresponding Graph/Chart)
    • Major Players in the Enteral Nutrition and Enteral Infant Nutrition Market
  • Parenteral Nutrition Market
    • Table 5: Leading Players in the Global Parenteral Nutrition Market (2013): Percentage Share Breakdown of Value Sales for Baxter International, Fresenius Kabi, B.Braun, Hospira and Others (includes corresponding Graph/Chart)
    • Leading Players Operating in the Market for Parenteral Nutrition
    • Select Parenteral Nutrition Products by Company

2. MARKET DRIVERS, TRENDS & ISSUES

  • Impact of Recession in Retrospect and the Road Ahead
  • Improving Healthcare Expenditure to Drive Demand
    • Table 6: Per-Capita Healthcare Expenditure in Select Regions (2013) (includes corresponding Graph/Chart)
    • Table 7: Healthcare Spending as a Percentage of GDP (2012) (includes corresponding Graph/Chart)
  • Aging Population: A Strong Growth Driver
    • Table 8: Global Population Statistics for the 65+ Age Group (2013) (includes corresponding Graph/Chart)
    • Table 9: Elderly Population (60+ Years) as a Percentage of the Total Population (2012 & 2050) (includes corresponding Graph/Chart)
    • Table 10: Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)
  • Rising Incidence of Chronic Diseases to Kindle Market Growth
  • World Cancer Statistics: Incidence and Mortality Data
    • Table 11: Worldwide Incidence of Cancer (2013, 2020 & 2030): Number of New Cases Diagnosed
    • Table 12: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
    • Table 13: World Cancer Mortality by Geographic Region and Gender (2012): Number of Cancer-Related Deaths (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
    • Table 14: New Cancer Cases in the World by Affected Site (2012) (In Thousands) (includes corresponding Graph/Chart)
    • Table 15: Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung & Bronchus, Prostate, Colorectal and Liver Cancers (includes corresponding Graph/Chart)
    • Table 16: Global Incidence of Common Cancers in Women (2012): Number of New Cases Reported in Thousands for Breast, Colorectal, Lung & Bronchus and Liver Cancers (includes corresponding Graph/Chart)
    • Table 17: Global Cancer Mortality in Men for Select Cancers (2012): Number of Deaths in Thousands for Lung & Bronchus, Liver, Colorectal and Prostate Cancers (includes corresponding Graph/Chart)
    • Table 18: Global Cancer Mortality in Women for Select Cancers (2012): Number of Deaths in Thousands for Breast, Lung & Bronchus, Colorectal and Liver (includes corresponding Graph/Chart)
    • Cancer Prone Sites based on Age
  • Diabetes Mellitus: Another Major Chronic Condition
    • Table 19: Global Diabetes Mellitus Incidence among Ages 20-79 (2014E & 2035P): Prevalence (in Millions) and Percentage Share by Geographic Region (includes corresponding Graph/Chart)
    • Table 20: Percentage Increase in DM Incidence among Ages 20-79 Worldwide by Geographic Region: 2013-2035 (includes corresponding Graph/Chart)
    • Table 21: Countries with Highest Number of People with DM (in Millions) among Ages 20-79: 2014E & 2035P (includes corresponding Graph/Chart)
    • Table 22: Prevalence of Diabetes Mellitus in North America (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for the US, Canada and Mexico (includes corresponding Graph/Chart)
    • Table 23: Prevalence of Diabetes Mellitus in Europe (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 47 Countries in the Region
    • Table 24: Prevalence of Diabetes Mellitus in South East Asia (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for Bangladesh, Bhutan, India, Maldives, Mauritius, Nepal, and Sri Lanka
    • Table 25: Prevalence of Diabetes Mellitus in Western Asia, Pacific Regions (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 27 Countries in the Region
    • Table 26: Prevalence of Diabetes Mellitus in South & Central America (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 20 Countries in the Region
    • Table 27: Prevalence of Diabetes Mellitus in Africa (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 27 Countries in the Region
    • Table 28: Prevalence of Diabetes Mellitus in Middle East & North Africa (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 19 Countries in the Region
    • Parental Nutrition for Diabetes Patients with Non-functional Gastrointestinal Tract
  • Global HIV Statistics
    • Table 29: Global Prevalence of HIV Infection in 2013 by Region (in Millions) (includes corresponding Graph/Chart)
    • Table 30: Newly Infected HIV Population in 2013 by Region (in Thousands) (includes corresponding Graph/Chart)
  • Table 31: Global HIV Related Deaths in 2013 by Region (in Thousands) (includes corresponding Graph/Chart)
  • Clinical Nutrition in Treatment of Malnutrition: Significant Growth Opportunities
  • Non-volitional Nutritional Support Therapy - Vital for Combating Malnutrition during Hospitalization
  • Shift towards Home Care Boosts Demand for Clinical Nutrition Products
  • Changing Health and Social Care Factors Favor Home Enteral Feeding
  • Rising Number of Premature Births Drives Infant Clinical Nutrition Products Market
  • Preterm Birth Statistics from WHO
    • Table 32: Percentage of Preterm Births by Region: 2012) (includes corresponding Graph/Chart)
    • Table 33: Top Ten Countries with the Highest Number of Preterm Births (2012) (includes corresponding Graph/Chart)
    • Table 34: Top Ten Countries with the Highest Rates of Preterm Births (per 100 Live Births): 2012 (includes corresponding Graph/Chart)
  • Demand for Personalized Medicine to Bode Well for Clinical Nutrition Products Market
  • Product Innovations Blur the Lines between Medicine and Foods
  • Surging Demand for Omega-3 Fatty Acids-Fortified Clinical Nutrition Products
  • Advances in Enteral Feeding Devices: Positive Outlook for Enteral Nutrition Market
  • Rising Incidence of Pediatric Crohn's Disease Fuels Enteral Nutrition Market
  • Specialized Formula Products Inundate the Market
  • Soy-based Infant Formula Gains Popularity
  • Pre-mixed IV Solutions: A Step towards Safer Medication Practices
  • Growing Demand for Low-Cost Parenteral Nutrition Solutions
  • Rising Preference for Multi-Chamber Bags to Lower Cost of Parenteral Nutrition Therapy
  • Increasing Popularity of Intravenous Vitamin C for Cancer Treatment
  • Infection Control: A Prime Concern in Parenteral Nutrition
  • Complacency of Hospitals & Worker/Patient Safety: A Key Issue
  • Favorable Clinical Findings Strengthens Prospects for Enteral Nutrition
  • Rising Preference for Enteral Nutrition - A Threat to Parenteral Nutrition Market
  • Advantages and Disadvantages of Enteral Nutrition over Parenteral Nutrition
  • Major Challenges Confronting Medical Nutrition Products' Marketers
  • Barriers to Widespread Adoption of Clinical Nutrition Products
  • Reasons for Not Prescribing Clinical Nutrition Products

3. PRODUCT OVERVIEW

  • Clinical Nutrition: An Introduction
  • Diseases Indicating Administering of Clinical Nutrition
  • Advantages of Clinical Nutrition
  • Classification of Clinical Nutrition Products
  • Infant Nutrition Products
    • Table 35: Nutrient Specifications for Infant Formulas (per 100kcal)
    • List of Infant Nutrition Products
    • Types of Infant Nutrition Products
      • Specialized Milk-Based Formulas
      • Soy-based Infant Formula
      • Amino Acid-based Formulas
      • Probiotic Infant Formulas
      • Prebiotics in Infant Nutrition
      • Exempt Infant Formulas
      • Human Milk Oligosaccharides
      • Nutrition Products for Preterm Infants
      • Premature Infant Formula
      • Transitional Formulas
      • Human Milk Fortifiers
      • Metabolic Infant Formulas
      • Follow-up or Follow-on Formulas
      • Enteral Administration of Infant Formulas in Neonatal Intensive Care and General Healthcare Settings
      • Nipple Feeding
      • Tube Feeding
  • Enteral Nutrition Products
    • Table 36: Daily Electrolyte Requirements for Enteral Nutrition
    • Table 37: Daily Trace Element Requirement for Enteral Nutrition
    • Table 38: Daily Vitamin Requirements for Enteral Nutrition
    • Table 39: Daily Trace Element Requirements Enteral Nutrition in Infants
    • Table 40: Daily Vitamin Requirements for Enteral Nutrition in Infants
    • Enteral Nutrition by Age
      • Enteral Nutrition for Patients aged 21 and older
      • Enteral Nutrition for Patients below 21 Years
      • Various Types of Enteral Feeding or Tube Feeding
    • What Constitutes Enteral Nutrition Diets?
      • Home-Made Diets
      • Commercial Enteral Formulas
      • Elemental Formulas
      • Oligomeric Formulas
      • Polymeric Formulas
      • Special Formulas
      • Pulmonary Formulas
      • Liver Formulas
      • Renal Formulas
      • Diabetes Formulas
      • Gastrointestinal Dysfunction Formulas
      • Immuno-modulatory Formulas
    • Enteral Nutrition in Patients with Acute Renal Failure (ARF)
    • Table 41: Nutritional Requirements in Patients with ARF
    • Enteral Nutrition in Conservatively Treated Patients with Chronic Renal Failure (CRF)
    • Table 42: Recommendations for Protein Supply in Adult CRF Patients (in g/kgBW/day)
    • Table 43: Mineral Requirements for Patients with CRF
    • Enteral Nutrition in Haemodialysis Patients
    • Enteral Nutrition in Chronic Ambulatory Peritoneal Dialysis (CAPD) Patients
    • Table 44: Recommendations for Protein and Energy Supply in Adult Patients on Routine Hemodialysis and CAPD
    • Table 45: Mineral Requirements of Patients on Haemodialysis and Chronic Ambulatory Peritoneal Dialysis
    • Complications of Enteral Feeding
      • Complications Associated with Enteral Tube Feeding
  • Parenteral Nutrition
    • Sources of Parenteral Solutions
    • Routes of Administration
    • Types of Parenteral Nutrition Solutions
      • Total Parenteral Nutrition (TPN)
    • Table 46: Daily Requirements for Total Parenteral Nutrition (TPN) in Adults
    • Table 47: Daily Recommended Parenteral Nutritional Intakes for Newborns
      • TPN Formulation
      • Partial Parenteral Nutrition (PPN)
      • Home Parenteral Nutrition
    • Parenteral Nutrition Formulations
      • Standard Solutions
      • Three-in-One Standard Bags
      • Two-in-one Standard Bags
      • Individual Solutions
      • Non-Standard Solutions
    • Classification of Parenteral Nutrition by Type of Nutrients
      • Amino Acids
      • Carbohydrates
      • Lipids
      • Minerals & Electrolytes
    • Table 48: Daily Electrolyte Requirements for Parenteral Nutrition
      • Micronutrients
      • Vitamins
    • Table 49: Daily Vitamin Requirements for Parenteral Nutrition
      • Trace Elements
    • Table 50: Daily Trace Element Requirement for Parenteral Nutrition
    • Large and Small Volume Parenteral Solutions
      • Large Volume Parenteral (LVP) Solutions
      • Small Volume Parenteral (SVP) Solutions
    • IV Fat Emulsions - Enabling Maintenance of Bodyweight

4. PRODUCT INNOVATIONS/INTRODUCTIONS/ APPROVALS

  • Otsuka Introduces HINE E-GEL Concentrated Liquid Nutrition Product
  • Alaska Introduces Friso 4 Infant Formula
  • Fresenius Kabi Obtains FDA Approval for Perikabiven® and Kabiven®
  • B. Braun Obtains FDA Approval for Nutrilipid® 20% for Parenteral Nutrition
  • Ingredion Europe Introduces UNI-PURE IMF 2332 and UNI-PURE IMF 8561 Infant Nutrition Product
  • Fonterra China to Launch Self-Branded Infant Formula in China
  • FDA Clears Fresenius Kabi for Emergency Import of Injectionable TPN Drugs
  • Marck Biosciences Receives MCC Approval for Six Pharma Products
  • Restore Health Pharmacy Launches High Quality Nutritional Supplement
  • Inergetics Introduces Surgex Ready to Drink Nutritional Beverage
  • Arla Foods Ingredients Introduces Revolutionary Whey Protein
  • Nestle Health Science Rolls Out SpikeRight® PLUS for Enteral Safety
  • Claris Receives USFDA Approval for Marketing Products in the US

5. RECENT INDUSTRY ACTIVITY

  • Nestle Sets Up Health Science Manufacturing Plant
  • Fonterra to Buy Stake in Beingmate
  • Fonterra Collaborates with Beingmate to Meet Infant Formula Demand
  • Baxter Recalls Select Lots of Parenteral Nutrition Products
  • ITH Pharma Recalls Lipid Phase Parenteral Nutrition Products
  • Unibrands and ICI to Market and Distribute Morinaga's Infant Formula in Pakistan
  • Abbott Receives Approval for ENEVO™ Liquid for Enteral Use
  • Nestle to Construct Infant Formula Plant in Mexico
  • Abbott Inaugurates Nutrition Production Facility in Haiti
  • Baxter Recalls Select Lots of Premix Parenteral Nutrition Products
  • Baxter Collaborates with JW Holdings for Omega 3 Lipids
  • Mead Johnson Establishes New Manufacturing and Research & Development Complex
  • Nestle Health Science Purchases Pamlab
  • Aspen Acquires IP Rights in Infant Nutritional Businesses of Nestle
  • Danone Completes Acquisition of Wockhardt's Nutrition Business
  • Abbott Nutrition Discontinues Enteral Device Business in the US and Puerto Rico
  • Danone Recalls Infant Formula Products in Asia
  • Yasheng Group Enters Joint Venture with IBC International LLC
  • Humana Establishes Offices in UAE
  • FDA Approves Clinolipid Lipid Injectable Emulsion
  • Nestle Acquires Pfizer Nutrition
  • Aperture Health Takes Over Triad Therapeutics
  • B Braun Acquires Nutrichem
  • Mead Johnson Nutrition Enters into Joint Venture with Sancor
  • Abbott Plans Collaboration with Syngene for Nutrition R&D Unit
  • AarhusKarlshamn Expands Capacity to Produce InFat™
  • Abbott to Construct Nutrition Production Facility in Ohio
  • BioGaia Enters into a Collaboration Agreement with Nestle
  • Claris Lifesciences Enters into JV with Otsuka Pharma and Mitsui for Indian Market

6. FOCUS ON SELECT GLOBAL PLAYERS

  • Abbott Nutrition (US)
  • American HomePatient, Inc. (US)
  • Baxter International, Inc. (US)
  • B. Braun Melsungen AG (Germany)
  • Claris Lifesciences Ltd. (India)
  • Groupe Danone (France)
  • Nutricia North America (US)
  • Fresenius Kabi AG (Germany)
  • Hospira, Inc. (US)
  • Mead Johnson Nutrition Company (US)
  • Meiji Co., Ltd. (Japan)
  • Nestle Health Science S.A (Switzerland)
  • Otsuka Pharmaceutical Factory, Inc. (Japan)
  • Sino-Swed Pharmaceutical Corp, Ltd. (China)

7. GLOBAL MARKET PERSPECTIVE

    • Table 51: World Recent Past, Current and Future Analysis for Clinical Nutrition Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 52: World Historic Review for Clinical Nutrition Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 53: World 14-Year Perspective for Clinical Nutrition Products by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa and Latin America Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)
    • Table 54: World Recent Past, Current and Future Analysis for Enteral Nutrition Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 55: World Historic Review for Enteral Nutrition Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 56: World 14-Year Perspective for Enteral Nutrition Products by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa and Latin America Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)
    • Table 57: World Recent Past, Current and Future Analysis for Infant Nutrition Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 58: World Historic Review for Infant Nutrition Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 59: World 14-Year Perspective for Infant Nutrition Products by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa and Latin America Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)
    • Table 60: World Recent Past, Current and Future Analysis for Parenteral Nutrition Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 61: World Historic Review for Parenteral Nutrition Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa and Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 62: World 14-Year Perspective for Parenteral Nutrition Products by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa and Latin America Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Market Overview
    • Rapidly Aging Demographics: A Major Driving Factor
    • Table 63: North American Elderly Population by Age Group (1975-2050) (includes corresponding Graph/Chart)
    • Rising Incidences of Chronic Diseases Enhance Need for Clinical Nutrition Products
      • Cancer Statistics in the US
    • Table 64: New Cancer Cases in US by State: 2014
    • Table 65: New Cancer Cases in the US by Gender and Affected Site: 2014
    • Table 66: Cancer Related Deaths in the US by Gender and Body Site: 2014
      • Prevalence of Diabetes Mellitus in North America
    • Table 67: Prevalence of Diabetes Mellitus in North America (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for the US, Canada and Mexico (includes corresponding Graph/Chart)
    • Table 68: North America Incidence of Type 1 Diabetes in Children (2012) (includes corresponding Graph/Chart)
    • An Insight into Infant Nutrition Market
    • Table 69: Baby & Toddler Nutrition Market in the US (2013): Percentage Share Breakdown of Value Sales by Segment (includes corresponding Graph/Chart)
      • Rising Number of Premature Births Augurs Well for Market Growth
    • Table 70: US Pre-term Birth Statistics (2012)
      • Strategic Innovations to Buoy Consumer Demand
      • Human Breast Milk-Like Infant Formulas to Gain Popularity
      • Competition
    • Table 71: Leading Players in the US Infant Formula Market (2013): Percentage Share Breakdown of Value Sales for Abbott, Mead Johnson, Nestle, and Others (includes corresponding Graph/Chart)
    • Table 72: Leading Infant Formula (Powder) Manufacturers in the US (2012): Percentage Share Breakdown of Value Sales* for Mead Johnson Nutrition Co, Abbott Nutrition, Nestle Healthcare Nutrition, Gerber Products Co, Private Label and Others (includes corresponding Graph/Chart)
    • Table 73: Leading Infant Formula Brands in the US (2012): Percentage Share Breakdown of Value Sales* for Enfamil Premium, Similac Advance, Similac Sensitive, Enfamil Gentlease, Gerber Good Start Gentle Plus, Gerber Good Start Gentle, Similac Advance Early Shield, Private label and Others (includes corresponding Graph/Chart)
      • WIC Contract and the Infant Formula Rebate Program
      • WIC's Infant Formula Rebate Program
    • Enteral Nutrition Market
      • Home Healthcare Fuels Demand for Home Enteral Nutrition Products
      • Enteral Nutrition Therapy to Treat Adult Malnutrition: Opportunities for Growth
      • Reimbursement Scenario for Enteral Nutrition Therapy
      • ENT Coverage under Part A
      • ENT Coverage under Part B
      • Reimbursements for Enteral Nutrients
    • Parenteral Nutrition Market: An Overview
      • Medicare Coverage for Parenteral Nutrition Therapy
      • Reimbursement Regulations to Hamper Market Growth
      • Shift towards Enteral Nutrition Therapies - A Threat to Parenteral Nutrition Market
      • Advantages and Disadvantages of Enteral Nutrition over Parenteral Nutrition
      • A.S.P.E.N. Practice Guidelines for Parenteral Nutrition
      • A.S.P.E.N. Guidelines for Parenteral Nutrition (as of 2004)
      • Impact of Patient Protection and Affordable Care Act on IV Solutions Market
    • Product Launches
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 74: US Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 75: US Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 76: US 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Outlook
    • Rising Incidence of Chronic Diseases: A Major Growth Driver
    • Table 77: New Cancer Cases in Canada by Gender and Affected Site: 2014
    • Table 78: New Cancer Cases in Canada by Province: 2014 (includes corresponding Graph/Chart)
    • Table 79: New Cancer Cases in Canada by Age Group: 2014 (includes corresponding Graph/Chart)
    • Table 80: Cancer Related Deaths in Canada by Gender and Affected Site: 2014 (includes corresponding Graph/Chart)
    • Table 81: Cancer Related Deaths in Canada by Province: 2014 (includes corresponding Graph/Chart)
    • Table 82: Cancer Related Deaths in Canada by Age Group: 2014 (includes corresponding Graph/Chart)
    • Table 83: Adult Diabetes Population by Age Group in Canada (2013) (In '000s) (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 84: Canadian Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 85: Canadian Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 86: Canadian 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Outlook
    • Rising Incidence of Chronic Diseases - A Prime Growth Driver
    • Table 87: Cancer Related Deaths by Age Groups: 2013
    • Table 88: Prevalence of Diabetes Mellitus in Japan (2013 & 2035) (includes corresponding Graph/Chart)
    • Product Launch
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 89: Japanese Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 90: Japanese Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 91: Japanese 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Outlook
    • Debt Crisis in Europe Affects Healthcare Industry
    • Aging Population & Rising Incidence of Chronic Diseases to Drive Growth
      • Aging Statistics
    • Table 92: Population Breakup by Age Group for Select European Countries: 2012 (as a Percentage of Total Population) (includes corresponding Graph/Chart)
      • Cancer Trends
    • Table 93: Cancer Incidence in Europe by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
      • Prevalence of Diabetes Mellitus in Europe
    • Table 94: Prevalence of Diabetes Mellitus in Europe (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 47 Countries in the Region
    • An Overview of Enteral Feeding Market in Europe
      • Prospering Enteral Nutrition Market: New Avenues for Ingredient Suppliers
      • Surging Interest in Home Healthcare: Gains for Enteral Nutrition Market
    • Infant Nutrition Market
      • Market Overview
      • The EC Directive on Infant Formulae and Follow-on Formulae
      • FSA's Control on Infant Formulas and Follow-on Formula Advertisements
  • B. Market Analytics
    • Table 95: European Recent Past, Current and Future Analysis for Clinical Nutrition Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 96: European Historic Review for Clinical Nutrition Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 97: European 14-Year Perspective for Clinical Nutrition Products by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)
    • Table 98: European Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 99: European Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 100: European 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Outlook
    • An Insight into the Market for Enteral Nutrition
    • Corporate Development
    • Groupe Danone - A Key Player
  • B. Market Analytics
    • Table 101: French Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 102: French Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 103: French 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Outlook
    • Entering Nutrition Market in Germany - An Overview
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 104: German Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 105: German Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 106: German 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 107: Italian Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 108: Italian Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 109: Italian 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Outlook
    • Corporate Development
  • B. Market Analytics
    • Table 110: UK Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 111: UK Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 112: UK 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

4e. SPAIN

  • Market Analysis
    • Table 113: Spanish Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 114: Spanish Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 115: Spanish 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

4f. RUSSIA

  • Market Analysis
    • Table 116: Russian Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 117: Russian Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 118: Russian 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Outlook
    • Product Launches
    • Strategic Corporate Developments
    • Nestle Health Science S.A (Switzerland) - A Key Player
  • B. Market Analytics
    • Table 119: Rest of Europe Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 120: Rest of Europe Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 121: Rest of Europe 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
    • Rising Diabetes Mellitus Cases in Asia-Pacific - Opportunity for Clinical Nutrition Companies
    • Table 122: Prevalence of Diabetes Mellitus in South East Asia (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for Bangladesh, Bhutan, India, Maldives, Mauritius, Nepal, and Sri Lanka
    • Table 123: Prevalence of Diabetes Mellitus in Western Asia, Pacific Regions (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 27 Countries in the Region
  • B. Market Analytics
    • Table 124: Asia-Pacific Recent Past, Current and Future Analysis for Clinical Nutrition Products by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 125: Asia-Pacific Historic Review for Clinical Nutrition Products by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 126: Asia-Pacific 14-Year Perspective for Clinical Nutrition Products by Geographic Region - Percentage Breakdown of Dollar Sales for China, India and Rest of Asia-Pacific Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)
    • Table 127: Asia-Pacific Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020
    • Table 128: Asia-Pacific Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 129: Asia-Pacific 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

5a. CHINA

  • A. Market Analysis
  • Outlook
    • Infant Formula Market: A Review
    • Table 130: Infant Formula Market in China (2013): Percentage Share Breakdown of Value Sales by Price Category (includes corresponding Graph/Chart)
      • Consolidation to Strengthen Infant Formula Industry
      • China Slaps Fines on Six Infant Formula Companies for Price-Fixing
      • Companies Lower Prices of Infant Formula Following Anti-Monopoly Probe
      • Key Challenges Facing Infant Formula Market
      • Rising Competition from Imported Products
      • Birth Rate
      • Need to Regain Consumer Confidence
      • Others
      • Competition
    • Table 131: Leading Players in the Chinese Infant Formula Market (2013): Percentage Share Breakdown of Value Sales for Abbott, Beingmate, Biostime, Danone, Daqing Dairy, Mead Johnson, Nestle, Yashili, and Others (includes corresponding Graph/Chart)
    • Parenteral Nutrition Market: An Insight
    • Enteral Nutrition Preparations Market: Competitive Landscape
    • Table 132: Leading Suppliers of Enteral Nutrition Preparations in China (2012): Percentage Share Breakdown of Value Sales for NUTRICIA (China), Sino-Swed Pharmaceutical Corp. Ltd, Novartis, Xi`an LIBANG Pharmaceutical Co, Ltd and Others (includes corresponding Graph/Chart)
    • Strategic Corporate Developments
    • Key Player
  • B. Market Analytics
    • Table 133: Chinese Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 134: Chinese Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 135: Chinese 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

5b. INDIA

  • A. Market Analysis
    • Outlook
    • Ready-to-Use Therapeutic Food to Treat Severe Acute Malnutrition in India
    • Table 136: Percentage Share Breakdown of Cost Composition of Ingredients Required for the Production of RUTF (includes corresponding Graph/Chart)
    • Strategic Corporate Developments
    • Key Player
  • B. Market Analytics
    • Table 137: Indian Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 138: Indian Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 139: Indian 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

5c. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
    • Australia: Home Enteral Nutrition in New South Wales
    • Product Launch
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 140: Rest of Asia-Pacific Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 141: Rest of Asia-Pacific Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 142: Rest of Asia-Pacific 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

6. MIDDLE EAST/AFRICA

  • A. Market Analysis
    • Outlook
    • Increasing Incidence of Chronic Conditions: Positive Growth Prospects
    • Table 143: Prevalence of Diabetes Mellitus in Africa (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 27 Countries in the Region
    • Table 144: Prevalence of Diabetes Mellitus in Middle East & North Africa (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 19 Countries in the Region
    • Corporate Development
  • B. Market Analytics
    • Table 145: Middle East/Africa Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 146: Middle East/Africa Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 147: Middle East/Africa 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

7. LATIN AMERICA

  • A. Market Analysis
    • Outlook
    • Rising Incidence of Diabetes in Latin America - Opportunity Indicator
    • Table 148: Prevalence of Diabetes Mellitus in South & Central America (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 20 Countries in the Region
  • B. Market Analytics
    • Table 149: Latin American Recent Past, Current and Future Analysis for Clinical Nutrition Products by Geographic Region - Brazil, Mexico and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 150: Latin American Historic Review for Clinical Nutrition Products by Geographic Region - Brazil, Mexico and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 151: Latin American 14-Year Perspective for Clinical Nutrition Products by Geographic Region - Percentage Breakdown of Dollar Sales for Brazil, Mexico and Rest of Latin America Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)
    • Table 152: Latin American Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 153: Latin American Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 154: Latin American 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

7a. BRAZIL

  • Market Analysis
    • Table 155: Brazilian Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 156: Brazilian Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 157: Brazilian 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

7b. MEXICO

  • Market Analysis
    • Table 158: Mexican Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 159: Mexican Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 160: Mexican 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

7c. REST OF LATIN AMERICA

  • A. Market Analysis
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 161: Rest of Latin America Recent Past, Current and Future Analysis for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 162: Rest of Latin America Historic Review for Clinical Nutrition Products by Product Type - Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 163: Rest of Latin America 14-Year Perspective for Clinical Nutrition Products by Product Type - Percentage Breakdown of Dollar Sales for Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition Markets for Years 2007, 2015 and 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top